propranolol has been researched along with Autoimmune Disease in 8 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated whether carvedilol protects against experimental autoimmune myocarditis (EAM) attributing to antioxidant properties." | 7.72 | Cardioprotective effects of carvedilol on acute autoimmune myocarditis. ( Kishimoto, C; Nimata, M; Shioji, K; Yuan, Z, 2004) |
| " Oral propranolol is currently the first choice in the treatment of alarming infantile hemangiomas." | 3.76 | Innovative therapeutics in pediatric dermatology. ( Frasin, A; Gelmetti, C; Restano, L, 2010) |
| "We investigated whether carvedilol protects against experimental autoimmune myocarditis (EAM) attributing to antioxidant properties." | 3.72 | Cardioprotective effects of carvedilol on acute autoimmune myocarditis. ( Kishimoto, C; Nimata, M; Shioji, K; Yuan, Z, 2004) |
| "Cardiac failure regressed and thyroid function normalized within ten days on propranolol, 4 x 40 mg and thiamazole 3 x 40 mg daily intravenously." | 3.69 | [Immunogenic hyperthyroidism with hyperdynamic heart failure and early cirrhotic transformation of the liver]. ( Fischer, MR; Gärtner, R; Huss, R; Spes, CH, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gelmetti, C | 1 |
| Frasin, A | 1 |
| Restano, L | 1 |
| Gomez Cruz, MJ | 1 |
| Jabbar, M | 1 |
| Saini, N | 1 |
| Eng, D | 1 |
| Crawford, B | 1 |
| Vazquez, DM | 1 |
| Menon, R | 1 |
| Chen, M | 1 |
| Yuan, Z | 2 |
| Shioji, K | 2 |
| Kihara, Y | 1 |
| Takenaka, H | 1 |
| Onozawa, Y | 1 |
| Kishimoto, C | 2 |
| Nimata, M | 1 |
| Nishii, M | 1 |
| Inomata, T | 1 |
| Niwano, H | 1 |
| Takehana, H | 1 |
| Takeuchi, I | 1 |
| Nakano, H | 1 |
| Shinagawa, H | 1 |
| Naruke, T | 1 |
| Koitabashi, T | 1 |
| Nakahata, J | 1 |
| Izumi, T | 1 |
| Fischer, MR | 1 |
| Spes, CH | 1 |
| Huss, R | 1 |
| Gärtner, R | 1 |
| Perez Leiros, C | 1 |
| Borda, E | 1 |
| Adams, DD | 1 |
8 other studies available for propranolol and Autoimmune Disease
| Article | Year |
|---|---|
Innovative therapeutics in pediatric dermatology.
Topics: Adolescent; Adrenal Cortex Hormones; Alopecia Areata; Autoimmune Diseases; Child; Child, Preschool; | 2010 |
Severe hypoglycemia secondary to methimazole-induced insulin autoimmune syndrome in a 16 year old African-American male.
Topics: Adolescent; Antithyroid Agents; Autoantibodies; Autoimmune Diseases; Black or African American; Diaz | 2012 |
Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Autoimm | 2004 |
Cardioprotective effects of carvedilol on acute autoimmune myocarditis.
Topics: Administration, Oral; Animals; Autoimmune Diseases; Carbazoles; Cardiotonic Agents; Carvedilol; Dose | 2004 |
Beta2-Adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2-adrenergic stimulants as new therapeutic agents for myocarditis.
Topics: Adrenergic beta-Agonists; Animals; Autoimmune Diseases; Disease Models, Animal; DNA Primers; Ethanol | 2006 |
[Immunogenic hyperthyroidism with hyperdynamic heart failure and early cirrhotic transformation of the liver].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Autoi | 1997 |
Characterization of (-)-(3H)-DHA binding to intact mouse lymphocytes: effect of experimental autoimmune orchitis on beta-adrenoceptor expression.
Topics: Alprenolol; Animals; Autoimmune Diseases; Binding, Competitive; Dihydroalprenolol; Kinetics; Lymphoc | 1986 |
Rational management of thyroid auto-immune disease.
Topics: Adrenal Cortex Hormones; Antithyroid Agents; Autoimmune Diseases; Feedback; Humans; Hyperthyroidism; | 1974 |